BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34229751)

  • 1. Inflammation-related genes S100s, RNASE3, and CYBB and risk of leukemic transformation in patients with myelodysplastic syndrome with myelofibrosis.
    Hong M; Wu J; Ma L; Han X; Lu T; Wang Z; Zhao J; Liu L; Fu H; Huang W; Zheng W; He J; Wei G; Wang H; Chen Z; Huang H; Cai Z; Guo G; Sun J
    Biomark Res; 2021 Jul; 9(1):53. PubMed ID: 34229751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data.
    Wang N; Xu H; Li Q; Fang X; Liu J; Sui X; Zhang L; Jiang Y; Wang X
    Cancer Manag Res; 2020; 12():5881-5891. PubMed ID: 32765089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of clinical features and prognosis of primary myelodysplastic syndromes with myelofibrosis patients].
    Su T; Zhang PH; Xu ZF; Chen HS; Qin TJ; Zhang Y; Zhang HL; Fan LW; Pan LJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):378-82. PubMed ID: 22781796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profile of inflammatory and megakaryocytic factors in pediatric myelodysplastic syndrome with acute myelofibrosis.
    Hussein K; Suttorp M; Stucki-Koch A; Baumann I; Niemeyer CM; Kreipe H
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27048. PubMed ID: 29667765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
    Akiyama T; Matsunaga T; Terui T; Miyanishi K; Tanaka I; Sato T; Kuroda H; Takimoto R; Takayama T; Kato J; Yamauchi N; Kogawa K; Sakamaki S; Hirayama Y; Kohda K; Niitsu Y
    Leukemia; 2005 Sep; 19(9):1558-66. PubMed ID: 16034467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrosis-driving cells in patients with primary myelofibrosis and myelodysplastic syndromes with myelofibrosis].
    Cai YN; Zhang PH; Fang LH; Liu JQ; Li B; Xu ZF; Qin TJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):1002-1007. PubMed ID: 33445847
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
    Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
    Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome.
    Zhao Y; Guo J; Zhao S; Wang R; Shi L; Fang Y; Zhang Z; Song L; Wu D; Chang C
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of clinical features, gene mutation, and prognostic characteristics in de novo acute myeloid leukemia patients with myelofibrosis].
    Dong XY; Li YL; Wu CY; Liu YM; Zhang L; Cheng W; Shang BJ; Zhang L; Zhu ZM
    Zhonghua Xue Ye Xue Za Zhi; 2020 Sep; 41(9):731-736. PubMed ID: 33113604
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis.
    Imbert M; Nguyen D; Sultan C
    Leuk Res; 1992; 16(1):51-4. PubMed ID: 1732672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A t(3;8)(q26.2;q24) involving the EVI1 (MECOM) Gene.
    Liu K; Tirado CA
    J Assoc Genet Technol; 2018; 44(3):92-99. PubMed ID: 30208012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: A case report.
    Song K; Xu X; Li M
    Oncol Lett; 2015 Jul; 10(1):422-424. PubMed ID: 26171043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in patients with myelodysplastic syndrome.
    Gao L; Saeed A; Golem S; Zhang D; Woodroof J; McGuirk J; Ganguly S; Abhyankar S; Lin TL; Cui W
    Int J Lab Hematol; 2021 Feb; 43(1):99-109. PubMed ID: 32812335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Human BDH2 on the Cell Cycle, Differentiation, and Apoptosis and Associations with Leukemia Transformation in Myelodysplastic Syndrome.
    Yang WC; Lin SF; Wang SC; Tsai WC; Wu CC; Wu SC
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.
    Koster KL; Messerich NM; Volken T; Cogliatti S; Lehmann T; Graf L; Holbro A; Benz R; Demmer I; Jochum W; Rao TN; Silzle T
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
    Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
    Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Leukemia; 1993 Apr; 7(4):499-508. PubMed ID: 8464227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.